Concepedia

Publication | Open Access

CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open-Label, Dose-Escalation Study

DOIFull Paper Access

90

Citations

8

References

2012

Year

Salomon M. Stemmer, Ofer Benjaminov, Gal Medalia, N.B. Ciuraru, Michael H. Silverman, Sara Bar‐Yehuda, Sari Fishman, Zivit Harpaz, Motti Farbstein, Shira Cohen,
The Oncologist

Abstract

CF102 is safe and well-tolerated, showing favorable PK characteristics in Child Pugh A and B HCC patients, justifying further clinical development.

References

YearCitations

Page 1